Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ASP II (Ancrod Stroke Program) Study of Acute Viprinex for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute Ischemic Stroke

Next Previous
X
Search
Trial Profile

ASP II (Ancrod Stroke Program) Study of Acute Viprinex for Emergency Stroke: A Randomized, Double-Blind, Placebo-Controlled Study of Ancrod (Viprinex) in Subjects Beginning Treatment Within 6 Hours of the Onset of Acute Ischemic Stroke

Status: Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Nov 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ancrod (Primary)
  • Indications Embolism and thrombosis; Stroke
  • Focus Registrational; Therapeutic Use
  • Acronyms ASP-II

    • Most Recent Events

    • 14 Jan 2009 Following a detailed analysis of the recent interim results of this clinical trial, the company has decided not to develop Viprinex further for the treatment of acute ischemic stroke, as reported by Neurobiological Technologies in a media release.
    • 17 Dec 2008 Status changed is now discontinued, as reported by clinicaltrials.gov.
    • 17 Dec 2008 Status changed from recruiting to suspended. An analysis of trial data is expected in early 2009, results of which will determine whether further development of Ancrod will continue.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top